Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Marché des organisations de recherche sous contrat

ID: MRFR/HS/2389-CR
90 Pages
Satyendra Maurya
Last Updated: May 06, 2026

Rapport d'étude de marché sur les organisations de recherche sous contrat (CRO) : Taille, Part, Analyse des tendances par type de service (Services de recherche clinique, Services précliniques, Services de laboratoire, Services de conseil), par domaine thérapeutique (Oncologie, Cardiologie, Neurologie, Maladies infectieuses, Endocrinologie), par utilisateurs finaux (Entreprises pharmaceutiques, Entreprises de biotechnologie, Entreprises de dispositifs médicaux, Institutions académiques), par phase de développement (Préclinique, Phase I, Phase II, Phase III, Phase IV) et par région (Amérique du Nord, Europe, Amérique du Sud, Asie-Pacifique, Moyen-Orient et Afrique) - Perspectives de croissance et prévisions de l'industrie 2025 à 2035

Partager
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Contract Research Organization Market Infographic
Purchase Options
  1. 1 EXECUTIVE SUMMARY
    1. 1.1 Market Overview
    2. 1.2 Key Findings
    3. 1.3 Market Segmentation
    4. 1.4 Competitive Landscape
    5. 1.5 Challenges and Opportunities
    6. 1.6 Future Outlook
  2. 2 MARKET INTRODUCTION
    1. 2.1 Definition
    2. 2.2 Scope of the study
      1. 2.2.1 Research Objective
      2. 2.2.2 Assumption
      3. 2.2.3 Limitations
  3. 3 RESEARCH METHODOLOGY
    1. 3.1 Overview
    2. 3.2 Data Mining
    3. 3.3 Secondary Research
    4. 3.4 Primary Research
      1. 3.4.1 Primary Interviews and Information Gathering Process
      2. 3.4.2 Breakdown of Primary Respondents
    5. 3.5 Forecasting Model
    6. 3.6 Market Size Estimation
      1. 3.6.1 Bottom-Up Approach
      2. 3.6.2 Top-Down Approach
    7. 3.7 Data Triangulation
    8. 3.8 Validation
  4. 4 MARKET DYNAMICS
    1. 4.1 Overview
    2. 4.2 Drivers
    3. 4.3 Restraints
    4. 4.4 Opportunities
  5. 5 MARKET FACTOR ANALYSIS
    1. 5.1 Value chain Analysis
    2. 5.2 Porter's Five Forces Analysis
      1. 5.2.1 Bargaining Power of Suppliers
      2. 5.2.2 Bargaining Power of Buyers
      3. 5.2.3 Threat of New Entrants
      4. 5.2.4 Threat of Substitutes
      5. 5.2.5 Intensity of Rivalry
    3. 5.3 COVID-19 Impact Analysis
      1. 5.3.1 Market Impact Analysis
      2. 5.3.2 Regional Impact
      3. 5.3.3 Opportunity and Threat Analysis
  6. 6 CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, BY SERVICE TYPE (USD BILLION)
    1. 6.1 Clinical Research Services
    2. 6.2 Preclinical Services
    3. 6.3 Laboratory Services
    4. 6.4 Consulting Services
  7. 7 CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, BY THERAPEUTIC AREA (USD BILLION)
    1. 7.1 Oncology
    2. 7.2 Cardiology
    3. 7.3 Neurology
    4. 7.4 Infectious Diseases
    5. 7.5 Endocrinology
  8. 8 CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, BY END USER (USD BILLION)
    1. 8.1 Pharmaceutical Companies
    2. 8.2 Biotechnology Companies
    3. 8.3 Medical Device Companies
    4. 8.4 Academic Institutions
  9. 9 CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, BY PHASE OF DEVELOPMENT (USD BILLION)
    1. 9.1 Preclinical
    2. 9.2 Phase I
    3. 9.3 Phase II
    4. 9.4 Phase III
    5. 9.5 Phase IV
  10. 10 CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, BY REGIONAL (USD BILLION)
    1. 10.1 North America
      1. 10.1.1 US
      2. 10.1.2 Canada
    2. 10.2 Europe
      1. 10.2.1 Germany
      2. 10.2.2 UK
      3. 10.2.3 France
      4. 10.2.4 Russia
      5. 10.2.5 Italy
      6. 10.2.6 Spain
      7. 10.2.7 Rest of Europe
    3. 10.3 APAC
      1. 10.3.1 China
      2. 10.3.2 India
      3. 10.3.3 Japan
      4. 10.3.4 South Korea
      5. 10.3.5 Malaysia
      6. 10.3.6 Thailand
      7. 10.3.7 Indonesia
      8. 10.3.8 Rest of APAC
    4. 10.4 South America
      1. 10.4.1 Brazil
      2. 10.4.2 Mexico
      3. 10.4.3 Argentina
      4. 10.4.4 Rest of South America
    5. 10.5 MEA
      1. 10.5.1 GCC Countries
      2. 10.5.2 South Africa
      3. 10.5.3 Rest of MEA
  11. 11 COMPETITIVE LANDSCAPE
    1. 11.1 Overview
    2. 11.2 Competitive Analysis
    3. 11.3 Market share Analysis
    4. 11.4 Major Growth Strategy in the Contract Research Organization (CRO) Market
    5. 11.5 Competitive Benchmarking
    6. 11.6 Leading Players in Terms of Number of Developments in the Contract Research Organization (CRO) Market
    7. 11.7 Key developments and growth strategies
      1. 11.7.1 New Product Launch/Service Deployment
      2. 11.7.2 Merger & Acquisitions
      3. 11.7.3 Joint Ventures
    8. 11.8 Major Players Financial Matrix
      1. 11.8.1 Sales and Operating Income
      2. 11.8.2 Major Players R&D Expenditure. 2023
  12. 12 COMPANY PROFILES
    1. 12.1 Charles River Laboratories
      1. 12.1.1 Financial Overview
      2. 12.1.2 Products Offered
      3. 12.1.3 Key Developments
      4. 12.1.4 SWOT Analysis
      5. 12.1.5 Key Strategies
    2. 12.2 Parexel International
      1. 12.2.1 Financial Overview
      2. 12.2.2 Products Offered
      3. 12.2.3 Key Developments
      4. 12.2.4 SWOT Analysis
      5. 12.2.5 Key Strategies
    3. 12.3 Medpace
      1. 12.3.1 Financial Overview
      2. 12.3.2 Products Offered
      3. 12.3.3 Key Developments
      4. 12.3.4 SWOT Analysis
      5. 12.3.5 Key Strategies
    4. 12.4 PPD
      1. 12.4.1 Financial Overview
      2. 12.4.2 Products Offered
      3. 12.4.3 Key Developments
      4. 12.4.4 SWOT Analysis
      5. 12.4.5 Key Strategies
    5. 12.5 Advanced Clinical
      1. 12.5.1 Financial Overview
      2. 12.5.2 Products Offered
      3. 12.5.3 Key Developments
      4. 12.5.4 SWOT Analysis
      5. 12.5.5 Key Strategies
    6. 12.6 PRA Health Sciences
      1. 12.6.1 Financial Overview
      2. 12.6.2 Products Offered
      3. 12.6.3 Key Developments
      4. 12.6.4 SWOT Analysis
      5. 12.6.5 Key Strategies
    7. 12.7 IQVIA
      1. 12.7.1 Financial Overview
      2. 12.7.2 Products Offered
      3. 12.7.3 Key Developments
      4. 12.7.4 SWOT Analysis
      5. 12.7.5 Key Strategies
    8. 12.8 Syneos Health
      1. 12.8.1 Financial Overview
      2. 12.8.2 Products Offered
      3. 12.8.3 Key Developments
      4. 12.8.4 SWOT Analysis
      5. 12.8.5 Key Strategies
    9. 12.9 Icon plc
      1. 12.9.1 Financial Overview
      2. 12.9.2 Products Offered
      3. 12.9.3 Key Developments
      4. 12.9.4 SWOT Analysis
      5. 12.9.5 Key Strategies
    10. 12.10 KCR
      1. 12.10.1 Financial Overview
      2. 12.10.2 Products Offered
      3. 12.10.3 Key Developments
      4. 12.10.4 SWOT Analysis
      5. 12.10.5 Key Strategies
    11. 12.11 Clinical Research Services
      1. 12.11.1 Financial Overview
      2. 12.11.2 Products Offered
      3. 12.11.3 Key Developments
      4. 12.11.4 SWOT Analysis
      5. 12.11.5 Key Strategies
    12. 12.12 WuXi AppTec
      1. 12.12.1 Financial Overview
      2. 12.12.2 Products Offered
      3. 12.12.3 Key Developments
      4. 12.12.4 SWOT Analysis
      5. 12.12.5 Key Strategies
    13. 12.13 BioClinica
      1. 12.13.1 Financial Overview
      2. 12.13.2 Products Offered
      3. 12.13.3 Key Developments
      4. 12.13.4 SWOT Analysis
      5. 12.13.5 Key Strategies
    14. 12.14 Covance
      1. 12.14.1 Financial Overview
      2. 12.14.2 Products Offered
      3. 12.14.3 Key Developments
      4. 12.14.4 SWOT Analysis
      5. 12.14.5 Key Strategies
    15. 12.15 CTI Clinical Trial and Consulting Services
      1. 12.15.1 Financial Overview
      2. 12.15.2 Products Offered
      3. 12.15.3 Key Developments
      4. 12.15.4 SWOT Analysis
      5. 12.15.5 Key Strategies
  13. 13 APPENDIX
    1. 13.1 References
    2. 13.2 Related Reports
  14. LIST OF TABLES
  15. TABLE 1 LIST OF ASSUMPTIONS
  16. TABLE 2 NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  17. TABLE 3 NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  18. TABLE 4 NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  19. TABLE 5 NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  20. TABLE 6 NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  21. TABLE 7 US CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  22. TABLE 8 US CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  23. TABLE 9 US CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  24. TABLE 10 US CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  25. TABLE 11 US CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  26. TABLE 12 CANADA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  27. TABLE 13 CANADA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  28. TABLE 14 CANADA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  29. TABLE 15 CANADA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  30. TABLE 16 CANADA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  31. TABLE 17 EUROPE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  32. TABLE 18 EUROPE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  33. TABLE 19 EUROPE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  34. TABLE 20 EUROPE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  35. TABLE 21 EUROPE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  36. TABLE 22 GERMANY CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  37. TABLE 23 GERMANY CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  38. TABLE 24 GERMANY CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  39. TABLE 25 GERMANY CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  40. TABLE 26 GERMANY CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  41. TABLE 27 UK CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  42. TABLE 28 UK CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  43. TABLE 29 UK CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  44. TABLE 30 UK CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  45. TABLE 31 UK CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  46. TABLE 32 FRANCE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  47. TABLE 33 FRANCE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  48. TABLE 34 FRANCE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  49. TABLE 35 FRANCE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  50. TABLE 36 FRANCE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  51. TABLE 37 RUSSIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  52. TABLE 38 RUSSIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  53. TABLE 39 RUSSIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  54. TABLE 40 RUSSIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  55. TABLE 41 RUSSIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  56. TABLE 42 ITALY CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  57. TABLE 43 ITALY CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  58. TABLE 44 ITALY CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  59. TABLE 45 ITALY CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  60. TABLE 46 ITALY CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  61. TABLE 47 SPAIN CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  62. TABLE 48 SPAIN CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  63. TABLE 49 SPAIN CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  64. TABLE 50 SPAIN CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  65. TABLE 51 SPAIN CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  66. TABLE 52 REST OF EUROPE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  67. TABLE 53 REST OF EUROPE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  68. TABLE 54 REST OF EUROPE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  69. TABLE 55 REST OF EUROPE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  70. TABLE 56 REST OF EUROPE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  71. TABLE 57 APAC CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  72. TABLE 58 APAC CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  73. TABLE 59 APAC CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  74. TABLE 60 APAC CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  75. TABLE 61 APAC CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  76. TABLE 62 CHINA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  77. TABLE 63 CHINA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  78. TABLE 64 CHINA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  79. TABLE 65 CHINA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  80. TABLE 66 CHINA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  81. TABLE 67 INDIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  82. TABLE 68 INDIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  83. TABLE 69 INDIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  84. TABLE 70 INDIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  85. TABLE 71 INDIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  86. TABLE 72 JAPAN CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  87. TABLE 73 JAPAN CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  88. TABLE 74 JAPAN CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  89. TABLE 75 JAPAN CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  90. TABLE 76 JAPAN CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  91. TABLE 77 SOUTH KOREA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  92. TABLE 78 SOUTH KOREA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  93. TABLE 79 SOUTH KOREA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  94. TABLE 80 SOUTH KOREA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  95. TABLE 81 SOUTH KOREA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  96. TABLE 82 MALAYSIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  97. TABLE 83 MALAYSIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  98. TABLE 84 MALAYSIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  99. TABLE 85 MALAYSIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  100. TABLE 86 MALAYSIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  101. TABLE 87 THAILAND CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  102. TABLE 88 THAILAND CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  103. TABLE 89 THAILAND CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  104. TABLE 90 THAILAND CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  105. TABLE 91 THAILAND CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  106. TABLE 92 INDONESIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  107. TABLE 93 INDONESIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  108. TABLE 94 INDONESIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  109. TABLE 95 INDONESIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  110. TABLE 96 INDONESIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  111. TABLE 97 REST OF APAC CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  112. TABLE 98 REST OF APAC CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  113. TABLE 99 REST OF APAC CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  114. TABLE 100 REST OF APAC CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  115. TABLE 101 REST OF APAC CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  116. TABLE 102 SOUTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  117. TABLE 103 SOUTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  118. TABLE 104 SOUTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  119. TABLE 105 SOUTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  120. TABLE 106 SOUTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  121. TABLE 107 BRAZIL CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  122. TABLE 108 BRAZIL CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  123. TABLE 109 BRAZIL CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  124. TABLE 110 BRAZIL CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  125. TABLE 111 BRAZIL CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  126. TABLE 112 MEXICO CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  127. TABLE 113 MEXICO CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  128. TABLE 114 MEXICO CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  129. TABLE 115 MEXICO CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  130. TABLE 116 MEXICO CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  131. TABLE 117 ARGENTINA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  132. TABLE 118 ARGENTINA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  133. TABLE 119 ARGENTINA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  134. TABLE 120 ARGENTINA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  135. TABLE 121 ARGENTINA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  136. TABLE 122 REST OF SOUTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  137. TABLE 123 REST OF SOUTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  138. TABLE 124 REST OF SOUTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  139. TABLE 125 REST OF SOUTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  140. TABLE 126 REST OF SOUTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  141. TABLE 127 MEA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  142. TABLE 128 MEA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  143. TABLE 129 MEA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  144. TABLE 130 MEA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  145. TABLE 131 MEA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  146. TABLE 132 GCC COUNTRIES CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  147. TABLE 133 GCC COUNTRIES CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  148. TABLE 134 GCC COUNTRIES CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  149. TABLE 135 GCC COUNTRIES CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  150. TABLE 136 GCC COUNTRIES CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  151. TABLE 137 SOUTH AFRICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  152. TABLE 138 SOUTH AFRICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  153. TABLE 139 SOUTH AFRICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  154. TABLE 140 SOUTH AFRICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  155. TABLE 141 SOUTH AFRICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  156. TABLE 142 REST OF MEA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY SERVICE TYPE, 2019-2035 (USD BILLIONS)
  157. TABLE 143 REST OF MEA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD BILLIONS)
  158. TABLE 144 REST OF MEA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
  159. TABLE 145 REST OF MEA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY PHASE OF DEVELOPMENT, 2019-2035 (USD BILLIONS)
  160. TABLE 146 REST OF MEA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
  161. TABLE 147 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  162. TABLE 148 ACQUISITION/PARTNERSHIP
  163. LIST OF FIGURES
  164. FIGURE 1 MARKET SYNOPSIS
  165. FIGURE 2 NORTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS
  166. FIGURE 3 US CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  167. FIGURE 4 US CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  168. FIGURE 5 US CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  169. FIGURE 6 US CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  170. FIGURE 7 US CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  171. FIGURE 8 CANADA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  172. FIGURE 9 CANADA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  173. FIGURE 10 CANADA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  174. FIGURE 11 CANADA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  175. FIGURE 12 CANADA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  176. FIGURE 13 EUROPE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS
  177. FIGURE 14 GERMANY CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  178. FIGURE 15 GERMANY CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  179. FIGURE 16 GERMANY CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  180. FIGURE 17 GERMANY CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  181. FIGURE 18 GERMANY CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  182. FIGURE 19 UK CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  183. FIGURE 20 UK CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  184. FIGURE 21 UK CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  185. FIGURE 22 UK CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  186. FIGURE 23 UK CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  187. FIGURE 24 FRANCE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  188. FIGURE 25 FRANCE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  189. FIGURE 26 FRANCE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  190. FIGURE 27 FRANCE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  191. FIGURE 28 FRANCE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  192. FIGURE 29 RUSSIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  193. FIGURE 30 RUSSIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  194. FIGURE 31 RUSSIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  195. FIGURE 32 RUSSIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  196. FIGURE 33 RUSSIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  197. FIGURE 34 ITALY CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  198. FIGURE 35 ITALY CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  199. FIGURE 36 ITALY CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  200. FIGURE 37 ITALY CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  201. FIGURE 38 ITALY CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  202. FIGURE 39 SPAIN CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  203. FIGURE 40 SPAIN CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  204. FIGURE 41 SPAIN CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  205. FIGURE 42 SPAIN CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  206. FIGURE 43 SPAIN CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  207. FIGURE 44 REST OF EUROPE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  208. FIGURE 45 REST OF EUROPE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  209. FIGURE 46 REST OF EUROPE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  210. FIGURE 47 REST OF EUROPE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  211. FIGURE 48 REST OF EUROPE CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  212. FIGURE 49 APAC CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS
  213. FIGURE 50 CHINA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  214. FIGURE 51 CHINA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  215. FIGURE 52 CHINA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  216. FIGURE 53 CHINA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  217. FIGURE 54 CHINA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  218. FIGURE 55 INDIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  219. FIGURE 56 INDIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  220. FIGURE 57 INDIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  221. FIGURE 58 INDIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  222. FIGURE 59 INDIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  223. FIGURE 60 JAPAN CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  224. FIGURE 61 JAPAN CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  225. FIGURE 62 JAPAN CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  226. FIGURE 63 JAPAN CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  227. FIGURE 64 JAPAN CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  228. FIGURE 65 SOUTH KOREA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  229. FIGURE 66 SOUTH KOREA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  230. FIGURE 67 SOUTH KOREA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  231. FIGURE 68 SOUTH KOREA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  232. FIGURE 69 SOUTH KOREA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  233. FIGURE 70 MALAYSIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  234. FIGURE 71 MALAYSIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  235. FIGURE 72 MALAYSIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  236. FIGURE 73 MALAYSIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  237. FIGURE 74 MALAYSIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  238. FIGURE 75 THAILAND CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  239. FIGURE 76 THAILAND CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  240. FIGURE 77 THAILAND CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  241. FIGURE 78 THAILAND CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  242. FIGURE 79 THAILAND CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  243. FIGURE 80 INDONESIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  244. FIGURE 81 INDONESIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  245. FIGURE 82 INDONESIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  246. FIGURE 83 INDONESIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  247. FIGURE 84 INDONESIA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  248. FIGURE 85 REST OF APAC CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  249. FIGURE 86 REST OF APAC CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  250. FIGURE 87 REST OF APAC CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  251. FIGURE 88 REST OF APAC CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  252. FIGURE 89 REST OF APAC CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  253. FIGURE 90 SOUTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS
  254. FIGURE 91 BRAZIL CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  255. FIGURE 92 BRAZIL CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  256. FIGURE 93 BRAZIL CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  257. FIGURE 94 BRAZIL CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  258. FIGURE 95 BRAZIL CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  259. FIGURE 96 MEXICO CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  260. FIGURE 97 MEXICO CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  261. FIGURE 98 MEXICO CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  262. FIGURE 99 MEXICO CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  263. FIGURE 100 MEXICO CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  264. FIGURE 101 ARGENTINA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  265. FIGURE 102 ARGENTINA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  266. FIGURE 103 ARGENTINA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  267. FIGURE 104 ARGENTINA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  268. FIGURE 105 ARGENTINA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  269. FIGURE 106 REST OF SOUTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  270. FIGURE 107 REST OF SOUTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  271. FIGURE 108 REST OF SOUTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  272. FIGURE 109 REST OF SOUTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  273. FIGURE 110 REST OF SOUTH AMERICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  274. FIGURE 111 MEA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS
  275. FIGURE 112 GCC COUNTRIES CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  276. FIGURE 113 GCC COUNTRIES CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  277. FIGURE 114 GCC COUNTRIES CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  278. FIGURE 115 GCC COUNTRIES CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  279. FIGURE 116 GCC COUNTRIES CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  280. FIGURE 117 SOUTH AFRICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  281. FIGURE 118 SOUTH AFRICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  282. FIGURE 119 SOUTH AFRICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  283. FIGURE 120 SOUTH AFRICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  284. FIGURE 121 SOUTH AFRICA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  285. FIGURE 122 REST OF MEA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY SERVICE TYPE
  286. FIGURE 123 REST OF MEA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY THERAPEUTIC AREA
  287. FIGURE 124 REST OF MEA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY END USER
  288. FIGURE 125 REST OF MEA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY PHASE OF DEVELOPMENT
  289. FIGURE 126 REST OF MEA CONTRACT RESEARCH ORGANIZATION (CRO) MARKET ANALYSIS BY REGIONAL
  290. FIGURE 127 KEY BUYING CRITERIA OF CONTRACT RESEARCH ORGANIZATION (CRO) MARKET
  291. FIGURE 128 RESEARCH PROCESS OF MRFR
  292. FIGURE 129 DRO ANALYSIS OF CONTRACT RESEARCH ORGANIZATION (CRO) MARKET
  293. FIGURE 130 DRIVERS IMPACT ANALYSIS: CONTRACT RESEARCH ORGANIZATION (CRO) MARKET
  294. FIGURE 131 RESTRAINTS IMPACT ANALYSIS: CONTRACT RESEARCH ORGANIZATION (CRO) MARKET
  295. FIGURE 132 SUPPLY / VALUE CHAIN: CONTRACT RESEARCH ORGANIZATION (CRO) MARKET
  296. FIGURE 133 CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, BY SERVICE TYPE, 2025 (% SHARE)
  297. FIGURE 134 CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, BY SERVICE TYPE, 2019 TO 2035 (USD Billions)
  298. FIGURE 135 CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, BY THERAPEUTIC AREA, 2025 (% SHARE)
  299. FIGURE 136 CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, BY THERAPEUTIC AREA, 2019 TO 2035 (USD Billions)
  300. FIGURE 137 CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, BY END USER, 2025 (% SHARE)
  301. FIGURE 138 CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, BY END USER, 2019 TO 2035 (USD Billions)
  302. FIGURE 139 CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, BY PHASE OF DEVELOPMENT, 2025 (% SHARE)
  303. FIGURE 140 CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, BY PHASE OF DEVELOPMENT, 2019 TO 2035 (USD Billions)
  304. FIGURE 141 CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, BY REGIONAL, 2025 (% SHARE)
  305. FIGURE 142 CONTRACT RESEARCH ORGANIZATION (CRO) MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions)
  306. FIGURE 143 BENCHMARKING OF MAJOR COMPETITORS
    1. "

Segmentation du marché des organisations de recherche sous contrat (CRO)

  • Marché des organisations de recherche sous contrat (CRO) par type de service (milliards USD, 2019-2035)
    • Services de recherche clinique
    • Services précliniques
    • Services de laboratoire
    • Services de conseil

 

  • Marché des organisations de recherche sous contrat (CRO) par domaine thérapeutique (milliards USD, 2019-2035)
    • Oncologie
    • Cardiologie
    • Neurologie
    • Maladies infectieuses
    • Endocrinologie

 

  • Marché des organisations de recherche sous contrat (CRO) par utilisateur final (milliards USD, 2019-2035)
    • Entreprises pharmaceutiques
    • Entreprises de biotechnologie
    • Entreprises de dispositifs médicaux
    • Institutions académiques

 

  • Marché des organisations de recherche sous contrat (CRO) par phase de développement (milliards USD, 2019-2035)
    • Préclinique
    • Phase I
    • Phase II
    • Phase III
    • Phase IV

 

  • Marché des organisations de recherche sous contrat (CRO) par région (milliards USD, 2019-2035)
    • Amérique du Nord
    • Europe
    • Amérique du Sud
    • Asie-Pacifique
    • Moyen-Orient et Afrique

 

Perspectives régionales du marché des organisations de recherche sous contrat (CRO) (milliards USD, 2019-2035)

 

 

  • Perspectives de l'Amérique du Nord (milliards USD, 2019-2035)
    • Marché des organisations de recherche sous contrat (CRO) en Amérique du Nord par type de service
      • Services de recherche clinique
      • Services précliniques
      • Services de laboratoire
      • Services de conseil
    • Marché des organisations de recherche sous contrat (CRO) en Amérique du Nord par type de domaine thérapeutique
      • Oncologie
      • Cardiologie
      • Neurologie
      • Maladies infectieuses
      • Endocrinologie
    • Marché des organisations de recherche sous contrat (CRO) en Amérique du Nord par type d'utilisateur final
      • Entreprises pharmaceutiques
      • Entreprises de biotechnologie
      • Entreprises de dispositifs médicaux
      • Institutions académiques
    • Marché des organisations de recherche sous contrat (CRO) en Amérique du Nord par type de phase de développement
      • Préclinique
      • Phase I
      • Phase II
      • Phase III
      • Phase IV
    • Marché des organisations de recherche sous contrat (CRO) en Amérique du Nord par type régional
      • États-Unis
      • Canada
    • Perspectives des États-Unis (milliards USD, 2019-2035)
    • Marché des organisations de recherche sous contrat (CRO) aux États-Unis par type de service
      • Services de recherche clinique
      • Services précliniques
      • Services de laboratoire
      • Services de conseil
    • Marché des organisations de recherche sous contrat (CRO) aux États-Unis par type de domaine thérapeutique
      • Oncologie
      • Cardiologie
      • Neurologie
      • Maladies infectieuses
      • Endocrinologie
    • Marché des organisations de recherche sous contrat (CRO) aux États-Unis par type d'utilisateur final
      • Entreprises pharmaceutiques
      • Entreprises de biotechnologie
      • Entreprises de dispositifs médicaux
      • Institutions académiques
    • Marché des organisations de recherche sous contrat (CRO) aux États-Unis par type de phase de développement
      • Préclinique
      • Phase I
      • Phase II
      • Phase III
      • Phase IV
    • Perspectives du Canada (milliards USD, 2019-2035)
    • Marché des organisations de recherche sous contrat (CRO) au Canada par type de service
      • Services de recherche clinique
      • Services précliniques
      • Services de laboratoire
      • Services de conseil
    • Marché des organisations de recherche sous contrat (CRO) au Canada par type de domaine thérapeutique
      • Oncologie
      • Cardiologie
      • Neurologie
      • Maladies infectieuses
      • Endocrinologie
    • Marché des organisations de recherche sous contrat (CRO) au Canada par type d'utilisateur final
      • Entreprises pharmaceutiques
      • Entreprises de biotechnologie
      • Entreprises de dispositifs médicaux
      • Institutions académiques
    • Marché des organisations de recherche sous contrat (CRO) au Canada par type de phase de développement
      • Préclinique
      • Phase I
      • Phase II
      • Phase III
      • Phase IV
    • Perspectives de l'Europe (milliards USD, 2019-2035)
      • Marché des organisations de recherche sous contrat (CRO) en Europe par type de service
        • Services de recherche clinique
        • Services précliniques
        • Services de laboratoire
        • Services de conseil
      • Marché des organisations de recherche sous contrat (CRO) en Europe par type de domaine thérapeutique
        • Oncologie
        • Cardiologie
        • Neurologie
        • Maladies infectieuses
        • Endocrinologie
      • Marché des organisations de recherche sous contrat (CRO) en Europe par type d'utilisateur final
        • Entreprises pharmaceutiques
        • Entreprises de biotechnologie
        • Entreprises de dispositifs médicaux
        • Institutions académiques
      • Marché des organisations de recherche sous contrat (CRO) en Europe par type de phase de développement
        • Préclinique
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Marché des organisations de recherche sous contrat (CRO) en Europe par type régional
        • Allemagne
        • Royaume-Uni
        • France
        • Russie
        • Italie
        • Espagne
        • Reste de l'Europe
      • Perspectives de l'Allemagne (milliards USD, 2019-2035)
      • Marché des organisations de recherche sous contrat (CRO) en Allemagne par type de service
        • Services de recherche clinique
        • Services précliniques
        • Services de laboratoire
        • Services de conseil
      • Marché des organisations de recherche sous contrat (CRO) en Allemagne par type de domaine thérapeutique
        • Oncologie
        • Cardiologie
        • Neurologie
        • Maladies infectieuses
        • Endocrinologie
      • Marché des organisations de recherche sous contrat (CRO) en Allemagne par type d'utilisateur final
        • Entreprises pharmaceutiques
        • Entreprises de biotechnologie
        • Entreprises de dispositifs médicaux
        • Institutions académiques
      • Marché des organisations de recherche sous contrat (CRO) en Allemagne par type de phase de développement
        • Préclinique
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Perspectives du Royaume-Uni (milliards USD, 2019-2035)
      • Marché des organisations de recherche sous contrat (CRO) au Royaume-Uni par type de service
        • Services de recherche clinique
        • Services précliniques
        • Services de laboratoire
        • Services de conseil
      • Marché des organisations de recherche sous contrat (CRO) au Royaume-Uni par type de domaine thérapeutique
        • Oncologie
        • Cardiologie
        • Neurologie
        • Maladies infectieuses
        • Endocrinologie
      • Marché des organisations de recherche sous contrat (CRO) au Royaume-Uni par type d'utilisateur final
        • Entreprises pharmaceutiques
        • Entreprises de biotechnologie
        • Entreprises de dispositifs médicaux
        • Institutions académiques
      • Marché des organisations de recherche sous contrat (CRO) au Royaume-Uni par type de phase de développement
        • Préclinique
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Perspectives de la France (milliards USD, 2019-2035)
      • Marché des organisations de recherche sous contrat (CRO) en France par type de service
        • Services de recherche clinique
        • Services précliniques
        • Services de laboratoire
        • Services de conseil
      • Marché des organisations de recherche sous contrat (CRO) en France par type de domaine thérapeutique
        • Oncologie
        • Cardiologie
        • Neurologie
        • Maladies infectieuses
        • Endocrinologie
      • Marché des organisations de recherche sous contrat (CRO) en France par type d'utilisateur final
        • Entreprises pharmaceutiques
        • Entreprises de biotechnologie
        • Entreprises de dispositifs médicaux
        • Institutions académiques
      • Marché des organisations de recherche sous contrat (CRO) en France par type de phase de développement
        • Préclinique
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Perspectives de la Russie (milliards USD, 2019-2035)
      • Marché des organisations de recherche sous contrat (CRO) en Russie par type de service
        • Services de recherche clinique
        • Services précliniques
        • Services de laboratoire
        • Services de conseil
      • Marché des organisations de recherche sous contrat (CRO) en Russie par type de domaine thérapeutique
        • Oncologie
        • Cardiologie
        • Neurologie
        • Maladies infectieuses
        • Endocrinologie
      • Marché des organisations de recherche sous contrat (CRO) en Russie par type d'utilisateur final
        • Entreprises pharmaceutiques
        • Entreprises de biotechnologie
        • Entreprises de dispositifs médicaux
        • Institutions académiques
      • Marché des organisations de recherche sous contrat (CRO) en Russie par type de phase de développement
        • Préclinique
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Perspectives de l'Italie (milliards USD, 2019-2035)
      • Marché des organisations de recherche sous contrat (CRO) en Italie par type de service
        • Services de recherche clinique
        • Services précliniques
        • Services de laboratoire
        • Services de conseil
      • Marché des organisations de recherche sous contrat (CRO) en Italie par type de domaine thérapeutique
        • Oncologie
        • Cardiologie
        • Neurologie
        • Maladies infectieuses
        • Endocrinologie
      • Marché des organisations de recherche sous contrat (CRO) en Italie par type d'utilisateur final
        • Entreprises pharmaceutiques
        • Entreprises de biotechnologie
        • Entreprises de dispositifs médicaux
        • Institutions académiques
      • Marché des organisations de recherche sous contrat (CRO) en Italie par type de phase de développement
        • Préclinique
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Perspectives de l'Espagne (milliards USD, 2019-2035)
      • Marché des organisations de recherche sous contrat (CRO) en Espagne par type de service
        • Services de recherche clinique
        • Services précliniques
        • Services de laboratoire
        • Services de conseil
      • Marché des organisations de recherche sous contrat (CRO) en Espagne par type de domaine thérapeutique
        • Oncologie
        • Cardiologie
        • Neurologie
        • Maladies infectieuses
        • Endocrinologie
      • Marché des organisations de recherche sous contrat (CRO) en Espagne par type d'utilisateur final
        • Entreprises pharmaceutiques
        • Entreprises de biotechnologie
        • Entreprises de dispositifs médicaux
        • Institutions académiques
      • Marché des organisations de recherche sous contrat (CRO) en Espagne par type de phase de développement
        • Préclinique
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Perspectives du reste de l'Europe (milliards USD, 2019-2035)
      • Marché des organisations de recherche sous contrat (CRO) dans le reste de l'Europe par type de service
        • Services de recherche clinique
        • Services précliniques
        • Services de laboratoire
        • Services de conseil
      • Marché des organisations de recherche sous contrat (CRO) dans le reste de l'Europe par type de domaine thérapeutique
        • Oncologie
        • Cardiologie
        • Neurologie
        • Maladies infectieuses
        • Endocrinologie
      • Marché des organisations de recherche sous contrat (CRO) dans le reste de l'Europe par type d'utilisateur final
        • Entreprises pharmaceutiques
        • Entreprises de biotechnologie
        • Entreprises de dispositifs médicaux
        • Institutions académiques
      • Marché des organisations de recherche sous contrat (CRO) dans le reste de l'Europe par type de phase de développement
        • Préclinique
        • Phase I
        • Phase II
        • Phase III
        • Phase IV
      • Perspectives de l'APAC (milliards USD, 2019-2035)
        • Marché des organisations de recherche sous contrat (CRO) en APAC par type de service
          • Services de recherche clinique
          • Services précliniques
          • Services de laboratoire
          • Services de conseil
        • Marché des organisations de recherche sous contrat (CRO) en APAC par type de domaine thérapeutique
          • Oncologie
          • Cardiologie
          • Neurologie
          • Maladies infectieuses
          • Endocrinologie
        • Marché des organisations de recherche sous contrat (CRO) en APAC par type d'utilisateur final
          • Entreprises pharmaceutiques
          • Entreprises de biotechnologie
          • Entreprises de dispositifs médicaux
          • Institutions académiques
        • Marché des organisations de recherche sous contrat (CRO) en APAC par type de phase de développement
          • Préclinique
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • Marché des organisations de recherche sous contrat (CRO) en APAC par type régional
          • Chine
          • Inde
          • Japon
          • Corée du Sud
          • Malaisie
          • Thaïlande
          • Indonésie
          • Reste de l'APAC
        • Perspectives de la Chine (milliards USD, 2019-2035)
        • Marché des organisations de recherche sous contrat (CRO) en Chine par type de service
          • Services de recherche clinique
          • Services précliniques
          • Services de laboratoire
          • Services de conseil
        • Marché des organisations de recherche sous contrat (CRO) en Chine par type de domaine thérapeutique
          • Oncologie
          • Cardiologie
          • Neurologie
          • Maladies infectieuses
          • Endocrinologie
        • Marché des organisations de recherche sous contrat (CRO) en Chine par type d'utilisateur final
          • Entreprises pharmaceutiques
          • Entreprises de biotechnologie
          • Entreprises de dispositifs médicaux
          • Institutions académiques
        • Marché des organisations de recherche sous contrat (CRO) en Chine par type de phase de développement
          • Préclinique
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • Perspectives de l'Inde (milliards USD, 2019-2035)
        • Marché des organisations de recherche sous contrat (CRO) en Inde par type de service
          • Services de recherche clinique
          • Services précliniques
          • Services de laboratoire
          • Services de conseil
        • Marché des organisations de recherche sous contrat (CRO) en Inde par type de domaine thérapeutique
          • Oncologie
          • Cardiologie
          • Neurologie
          • Maladies infectieuses
          • Endocrinologie
        • Marché des organisations de recherche sous contrat (CRO) en Inde par type d'utilisateur final
          • Entreprises pharmaceutiques
          • Entreprises de biotechnologie
          • Entreprises de dispositifs médicaux
          • Institutions académiques
        • Marché des organisations de recherche sous contrat (CRO) en Inde par type de phase de développement
          • Préclinique
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • Perspectives du Japon (milliards USD, 2019-2035)
        • Marché des organisations de recherche sous contrat (CRO) au Japon par type de service
          • Services de recherche clinique
          • Services précliniques
          • Services de laboratoire
          • Services de conseil
        • Marché des organisations de recherche sous contrat (CRO) au Japon par type de domaine thérapeutique
          • Oncologie
          • Cardiologie
          • Neurologie
          • Maladies infectieuses
          • Endocrinologie
        • Marché des organisations de recherche sous contrat (CRO) au Japon par type d'utilisateur final
          • Entreprises pharmaceutiques
          • Entreprises de biotechnologie
          • Entreprises de dispositifs médicaux
          • Institutions académiques
        • Marché des organisations de recherche sous contrat (CRO) au Japon par type de phase de développement
          • Préclinique
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • Perspectives de la Corée du Sud (milliards USD, 2019-2035)
        • Marché des organisations de recherche sous contrat (CRO) en Corée du Sud par type de service
          • Services de recherche clinique
          • Services précliniques
          • Services de laboratoire
          • Services de conseil
        • Marché des organisations de recherche sous contrat (CRO) en Corée du Sud par type de domaine thérapeutique
          • Oncologie
          • Cardiologie
          • Neurologie
          • Maladies infectieuses
          • Endocrinologie
        • Marché des organisations de recherche sous contrat (CRO) en Corée du Sud par type d'utilisateur final
          • Entreprises pharmaceutiques
          • Entreprises de biotechnologie
          • Entreprises de dispositifs médicaux
          • Institutions académiques
        • Marché des organisations de recherche sous contrat (CRO) en Corée du Sud par type de phase de développement
          • Préclinique
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • Perspectives de la Malaisie (milliards USD, 2019-2035)
        • Marché des organisations de recherche sous contrat (CRO) en Malaisie par type de service
          • Services de recherche clinique
          • Services précliniques
          • Services de laboratoire
          • Services de conseil
        • Marché des organisations de recherche sous contrat (CRO) en Malaisie par type de domaine thérapeutique
          • Oncologie
          • Cardiologie
          • Neurologie
          • Maladies infectieuses
          • Endocrinologie
        • Marché des organisations de recherche sous contrat (CRO) en Malaisie par type d'utilisateur final
          • Entreprises pharmaceutiques
          • Entreprises de biotechnologie
          • Entreprises de dispositifs médicaux
          • Institutions académiques
        • Marché des organisations de recherche sous contrat (CRO) en Malaisie par type de phase de développement
          • Préclinique
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • Perspectives de la Thaïlande (milliards USD, 2019-2035)
        • Marché des organisations de recherche sous contrat (CRO) en Thaïlande par type de service
          • Services de recherche clinique
          • Services précliniques
          • Services de laboratoire
          • Services de conseil
        • Marché des organisations de recherche sous contrat (CRO) en Thaïlande par type de domaine thérapeutique
          • Oncologie
          • Cardiologie
          • Neurologie
          • Maladies infectieuses
          • Endocrinologie
        • Marché des organisations de recherche sous contrat (CRO) en Thaïlande par type d'utilisateur final
          • Entreprises pharmaceutiques
          • Entreprises de biotechnologie
          • Entreprises de dispositifs médicaux
          • Institutions académiques
        • Marché des organisations de recherche sous contrat (CRO) en Thaïlande par type de phase de développement
          • Préclinique
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • Perspectives de l'Indonésie (milliards USD, 2019-2035)
        • Marché des organisations de recherche sous contrat (CRO) en Indonésie par type de service
          • Services de recherche clinique
          • Services précliniques
          • Services de laboratoire
          • Services de conseil
        • Marché des organisations de recherche sous contrat (CRO) en Indonésie par type de domaine thérapeutique
          • Oncologie
          • Cardiologie
          • Neurologie
          • Maladies infectieuses
          • Endocrinologie
        • Marché des organisations de recherche sous contrat (CRO) en Indonésie par type d'utilisateur final
          • Entreprises pharmaceutiques
          • Entreprises de biotechnologie
          • Entreprises de dispositifs médicaux
          • Institutions académiques
        • Marché des organisations de recherche sous contrat (CRO) en Indonésie par type de phase de développement
          • Préclinique
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • Perspectives du reste de l'APAC (milliards USD, 2019-2035)
        • Marché des organisations de recherche sous contrat (CRO) dans le reste de l'APAC par type de service
          • Services de recherche clinique
          • Services précliniques
          • Services de laboratoire
          • Services de conseil
        • Marché des organisations de recherche sous contrat (CRO) dans le reste de l'APAC par type de domaine thérapeutique
          • Oncologie
          • Cardiologie
          • Neurologie
          • Maladies infectieuses
          • Endocrinologie
        • Marché des organisations de recherche sous contrat (CRO) dans le reste de l'APAC par type d'utilisateur final
          • Entreprises pharmaceutiques
          • Entreprises de biotechnologie
          • Entreprises de dispositifs médicaux
          • Institutions académiques
        • Marché des organisations de recherche sous contrat (CRO) dans le reste de l'APAC par type de phase de développement
          • Préclinique
          • Phase I
          • Phase II
          • Phase III
          • Phase IV
        • Perspectives de l'Amérique du Sud (milliards USD, 2019-2035)
          • Marché des organisations de recherche sous contrat (CRO) en Amérique du Sud par type de service
            • Services de recherche clinique
            • Services précliniques
            • Services de laboratoire
            • Services de conseil
          • Marché des organisations de recherche sous contrat (CRO) en Amérique du Sud par type de domaine thérapeutique
            • Oncologie
            • Cardiologie
            • Neurologie
            • Maladies infectieuses
            • Endocrinologie
          • Marché des organisations de recherche sous contrat (CRO) en Amérique du Sud par type d'utilisateur final
            • Entreprises pharmaceutiques
            • Entreprises de biotechnologie
            • Entreprises de dispositifs médicaux
            • Institutions académiques
          • Marché des organisations de recherche sous contrat (CRO) en Amérique du Sud par type de phase de développement
            • Préclinique
            • Phase I
            • Phase II
            • Phase III
            • Phase IV
          • Marché des organisations de recherche sous contrat (CRO) en Amérique du Sud par type régional
            • Brésil
            • Mexique
            • Argentine
            • Reste de l'Amérique du Sud
          • Perspectives du Brésil (milliards USD, 2019-2035)
          • Marché des organisations de recherche sous contrat (CRO) au Brésil par type de service
            • Services de recherche clinique
            • Services précliniques
            • Services de laboratoire
            • Services de conseil
          • Marché des organisations de recherche sous contrat (CRO) au Brésil par type de domaine thérapeutique
            • Oncologie
            • Cardiologie
            • Neurologie
            • Maladies infectieuses
            • Endocrinologie
          • Marché des organisations de recherche sous contrat (CRO) au Brésil par type d'utilisateur final
            • Entreprises pharmaceutiques
            • Entreprises de biotechnologie
            • Entreprises de dispositifs médicaux
            • Institutions académiques
          • Marché des organisations de recherche sous contrat (CRO) au Brésil par type de phase de développement
            • Préclinique
            • Phase I
            • Phase II
            • Phase III
            • Phase IV
          • Perspectives du Mexique (milliards USD, 2019-2035)
          • Marché des organisations de recherche sous contrat (CRO) au Mexique par type de service
            • Services de recherche clinique
            • Services précliniques
            • Services de laboratoire
            • Services de conseil
          • Marché des organisations de recherche sous contrat (CRO) au Mexique par type de domaine thérapeutique
            • Oncologie
            • Cardiologie
            • Neurologie
            • Maladies infectieuses
            • Endocrinologie
          • Marché des organisations de recherche sous contrat (CRO) au Mexique par type d'utilisateur final
            • Entreprises pharmaceutiques
            • Entreprises de biotechnologie
            • Entreprises de dispositifs médicaux
            • Institutions académiques
          • Marché des organisations de recherche sous contrat (CRO) au Mexique par type de phase de développement
            • Préclinique
            • Phase I
            • Phase II
            • Phase III
            • Phase IV
          • Perspectives de l'Argentine (milliards USD, 2019-2035)
          • Marché des organisations de recherche sous contrat (CRO) en Argentine par type de service
            • Services de recherche clinique
            • Services précliniques
            • Services de laboratoire
            • Services de conseil
          • Marché des organisations de recherche sous contrat (CRO) en Argentine par type de domaine thérapeutique
            • Oncologie
            • Cardiologie
            • Neurologie
            • Maladies infectieuses
            • Endocrinologie
          • Marché des organisations de recherche sous contrat (CRO) en Argentine par type d'utilisateur final
            • Entreprises pharmaceutiques
            • Entreprises de biotechnologie
            • Entreprises de dispositifs médicaux
            • Institutions académiques
          • Marché des organisations de recherche sous contrat (CRO) en Argentine par type de phase de développement
            • Préclinique
            • Phase I
            • Phase II
            • Phase III
            • Phase IV
          • Perspectives du reste de l'Amérique du Sud (milliards USD, 2019-2035)
          • Marché des organisations de recherche sous contrat (CRO) dans le reste de l'Amérique du Sud par type de service
            • Services de recherche clinique
            • Services précliniques
            • Services de laboratoire
            • Services de conseil
          • Marché des organisations de recherche sous contrat (CRO) dans le reste de l'Amérique du Sud par type de domaine thérapeutique
            • Oncologie
            • Cardiologie
            • Neurologie
            • Maladies infectieuses
            • Endocrinologie
          • Marché des organisations de recherche sous contrat (CRO) dans le reste de l'Amérique du Sud par type d'utilisateur final
            • Entreprises pharmaceutiques
            • Entreprises de biotechnologie
            • Entreprises de dispositifs médicaux
            • Institutions académiques
          • Marché des organisations de recherche sous contrat (CRO) dans le reste de l'Amérique du Sud par type de phase de développement
            • Préclinique
            • Phase I
            • Phase II
            • Phase III
            • Phase IV
          • Perspectives de la MEA (milliards USD, 2019-2035)
            • Marché des organisations de recherche sous contrat (CRO) dans la MEA par type de service
              • Services de recherche clinique
              • Services précliniques
              • Services de laboratoire
              • Services de conseil
            • Marché des organisations de recherche sous contrat (CRO) dans la MEA par type de domaine thérapeutique
              • Oncologie
              • Cardiologie
              • Neurologie
              • Maladies infectieuses
              • Endocrinologie
            • Marché des organisations de recherche sous contrat (CRO) dans la MEA par type d'utilisateur final
              • Entreprises pharmaceutiques
              • Entreprises de biotechnologie
              • Entreprises de dispositifs médicaux
              • Institutions académiques
            • Marché des organisations de recherche sous contrat (CRO) dans la MEA par type de phase de développement
              • Préclinique
              • Phase I
              • Phase II
              • Phase III
              • Phase IV
            • Marché des organisations de recherche sous contrat (CRO) dans la MEA par type régional
              • Pays du CCG
              • Africa du Sud
              • Reste de la MEA
            • Perspectives des pays du CCG (milliards USD, 2019-2035)
            • Marché des organisations de recherche sous contrat (CRO) dans les pays du CCG par type de service
              • Services de recherche clinique
              • Services précliniques
              • Services de laboratoire
              • Services de conseil
            • Marché des organisations de recherche sous contrat (CRO) dans les pays du CCG par type de domaine thérapeutique
              • Oncologie
              • Cardiologie
              • Neurologie
              • Maladies infectieuses
              • Endocrinologie
            • Marché des organisations de recherche sous contrat (CRO) dans les pays du CCG par type d'utilisateur final
              • Entreprises pharmaceutiques
              • Entreprises de biotechnologie
              • Entreprises de dispositifs médicaux
              • Institutions académiques
            • Marché des organisations de recherche sous contrat (CRO) dans les pays du CCG par type de phase de développement
              • Préclinique
              • Phase I
              • Phase II
              • Phase III
              • Phase IV
            • Perspectives de l'Afrique du Sud (milliards USD, 2019-2035)
            • Marché des organisations de recherche sous contrat (CRO) en Afrique du Sud par type de service
              • Services de recherche clinique
              • Services précliniques
              • Services de laboratoire
              • Services de conseil
            • Marché des organisations de recherche sous contrat (CRO) en Afrique du Sud par type de domaine thérapeutique
              • Oncologie
              • Cardiologie
              • Neurologie
              • Maladies infectieuses
              • Endocrinologie
            • Marché des organisations de recherche sous contrat (CRO) en Afrique du Sud par type d'utilisateur final
              • Entreprises pharmaceutiques
              • Entreprises de biotechnologie
              • Entreprises de dispositifs médicaux
              • Institutions académiques
            • Marché des organisations de recherche sous contrat (CRO) en Afrique du Sud par type de phase de développement
              • Préclinique
              • Phase I
              • Phase II
              • Phase III
              • Phase IV
            • Perspectives du reste de la MEA (milliards USD, 2019-2035)
            • Marché des organisations de recherche sous contrat (CRO) dans le reste de la MEA par type de service
              • Services de recherche clinique
              • Services précliniques
              • Services de laboratoire
              • Services de conseil
            • Marché des organisations de recherche sous contrat (CRO) dans le reste de la MEA par type de domaine thérapeutique
              • Oncologie
              • Cardiologie
              • Neurologie
              • Maladies infectieuses
              • Endocrinologie
            • Marché des organisations de recherche sous contrat (CRO) dans le reste de la MEA par type d'utilisateur final
              • Entreprises pharmaceutiques
              • Entreprises de biotechnologie
              • Entreprises de dispositifs médicaux
              • Institutions académiques
            • Marché des organisations de recherche sous contrat (CRO) dans le reste de la MEA par type de phase de développement
              • Préclinique
              • Phase I
              • Phase II
              • Phase III
              • Phase IV

 

 

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions